ZHAW Waedenswil: A new Approach in the Fight against Cancer

Biotechnet Switzerland

Authors

  • Markus Rimann Group Leader 3D Tissues and Biofabrication, ICBT , ZHAW Zurich University of Applied Sciences, Waedenswil, Switzerland. markus.rimann@zhaw.ch

DOI:

https://doi.org/10.2533/chimia.2018.166

Keywords:

Abstract

A happy coincidence brought Dr Markus Rimann from ZHAW Waedenswil together with Dr Andreas Meyer from the start-up FGen and PD Dr Emanuela Felley-Bosco, Molecular Oncologist at Zurich University Hospital, to develop a technology platform for the manufacture and high throughput analysis of single mesothelioma spheroids. Armin Picenoni, former student in Chemistry for the Life Sciences at ZHAW, confirmed everything in writing his Master Thesis on this Innosuisse project.
CHIMIA Vol. 72 No. 03(2018): Quality Aspects in Industrial Chemistry

Downloads

Published

2018-03-30

Issue

Vol. 72 No. 3 (2018): Quality Aspects in Industrial Chemistry

Section

Columns, Conference Reports

Categories

License

Copyright (c) 2018 Swiss Chemical Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

[1]
Chimia 2018, 72, 166, DOI: 10.2533/chimia.2018.166.